<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02287207</url>
  </required_header>
  <id_info>
    <org_study_id>S57231</org_study_id>
    <nct_id>NCT02287207</nct_id>
  </id_info>
  <brief_title>Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to determine the effect of transcranial direct current
      stimulation (tDCS) on brain activity and fine motor skills in patients with Parkinson's
      disease compared to healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pilot study will involve a double-blind, sham controlled cross-over design where
      participants will receive anodal and sham tDCS stimulation in a randomized order. Differences
      in brain activity and fine motor skill performance between groups and after tDCS stimulation
      will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in writing amplitude</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Centimeter (cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in writing velocity</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Centimeter per second (cm/s)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in speed on the Purdue Pegboard task</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Number of pegs placed in 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cortical excitability</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Motor Evoked Potentials (MEP) peak to peak amplitude and latency - Measured with single-pulse Transcranial Magnetic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Short-Latency Intracortical Inhibition (SICI)</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Measured with double-pulse Transcranial Magnetic Stimulation (TMS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cortical silent period (cSP)</measure>
    <time_frame>post-stimulation (immediately after) and retention (1 week)</time_frame>
    <description>Measured with single-pulse Transcranial Magnetic</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Transcranial Direct Current Stimulation</condition>
  <condition>Fine Motor Skills</condition>
  <condition>Handwriting</condition>
  <arm_group>
    <arm_group_label>Anodal tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 minutes, 1.0 mA unilateral-anodal motor cortex (M1) tDCS stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>20 minutes, sham tDCS stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <arm_group_label>Anodal tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with idiopathic PD, according to the UK Brain Bank criteria

          -  Hoehn and Yahr (H&amp;Y) stage II in the 'on'-phase of the medication cycle

          -  Right dominant PD

        Exclusion Criteria:

          -  Cognitive impairment (MMSE &lt; 23)

          -  Visuo-spatial deficits (measured by the Rey-Osterrieth Complex Figure (ROCF) test)

          -  Left-handedness (evaluated by the Edinburgh Handedness scale)

          -  Depression

          -  Pregnancy

          -  Alcohol abuse

          -  Aneurysm clips

          -  Pacemaker

          -  Neurostimulator

          -  Implemented defibrillator

          -  Magnetically activated implant or device

          -  Implemented pump

          -  Spinal cord simulator

          -  Implemented hearing aid

          -  Artificial or prosthetic limb

          -  Metal parts in the body

          -  Any external or internal metal

          -  Artificial heart valve

          -  Other implants

          -  History of brain surgery

          -  Migraine

          -  Family history of Epilepsy

          -  Other contra-indications for tDCS and Transcranial Magnetic Stimulation (TMS)

          -  Other neurological, psychiatric or interfering upper limb problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CatholicULeuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://gbiomed.kuleuven.be/english/research/50000743/nrrg1/nrrg.htm</url>
    <description>Neuromotor Rehabilitation Research Group - KU Leuven, Belgium</description>
  </link>
  <reference>
    <citation>Broeder S, Nackaerts E, Nieuwboer A, Smits-Engelsman BC, Swinnen SP, Heremans E. The effects of dual tasking on handwriting in patients with Parkinson's disease. Neuroscience. 2014 Mar 28;263:193-202. doi: 10.1016/j.neuroscience.2014.01.019. Epub 2014 Jan 19.</citation>
    <PMID>24447597</PMID>
  </reference>
  <reference>
    <citation>Nackaerts E, Vervoort G, Heremans E, Smits-Engelsman BC, Swinnen SP, Nieuwboer A. Relearning of writing skills in Parkinson's disease: a literature review on influential factors and optimal strategies. Neurosci Biobehav Rev. 2013 Mar;37(3):349-57. doi: 10.1016/j.neubiorev.2013.01.015. Epub 2013 Jan 16. Review.</citation>
    <PMID>23333265</PMID>
  </reference>
  <reference>
    <citation>Broeder S, Nackaerts E, Heremans E, Vervoort G, Meesen R, Verheyden G, Nieuwboer A. Transcranial direct current stimulation in Parkinson's disease: Neurophysiological mechanisms and behavioral effects. Neurosci Biobehav Rev. 2015 Oct;57:105-17. doi: 10.1016/j.neubiorev.2015.08.010. Epub 2015 Aug 20. Review.</citation>
    <PMID>26297812</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2014</study_first_posted>
  <last_update_submitted>June 6, 2016</last_update_submitted>
  <last_update_submitted_qc>June 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Alice Nieuwboer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

